ArticleACS ES&T water2026
Characterization of Ozonation Transformation Products of Flutamide and Azathioprine by UHPLC-Ion Mobility-High-Resolution Mass Spectrometry.
Article in ACS ES&T water, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ozonation is one of the most promising advanced oxidation processes to be implemented as quaternary treatment for the removal of micropollutants in wastewater treatment plants. However, there are some knowledge gaps that limit its implementation. First, the removal efficiency is not known for all pollutants, and second, knowledge about degradation byproducts is limited, as well as the toxicity of the treated waters. In this work, the removal efficiency of azathioprine and flutamide is studied, as well as the transformation products formed during ozonation. A lab-scale reactor was used for ozonation of the drugs in pure water, with ambient air as the source for ozone generation and liquid chromatography-ion mobility-high-resolution mass spectrometry for time-resolved process monitoring. Notably, azathioprine and flutamide were not completely removed by ozonation, with 49-54% remaining after the treatment. Furthermore, two transformation products of azathioprine and three of flutamide were identified, including previously unreported nitroaromatic transformation products of flutamide. While both parent compounds showed relatively low predicted toxicity, transformation products of flutamide exhibited higher predicted chronic toxicity. These results highlight the importance of considering transformation products during ozonation and suggest possible nitration reactions when ozone is generated from ambient air. Further experiments are needed to confirm this.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.